Stephens Investment Management Group LLC Lowers Position in HealthEquity, Inc. $HQY

Stephens Investment Management Group LLC trimmed its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 28.7% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 724,244 shares of the company’s stock after selling 292,089 shares during the period. Stephens Investment Management Group LLC’s holdings in HealthEquity were worth $68,637,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Simplify Asset Management Inc. purchased a new position in HealthEquity in the 3rd quarter worth approximately $1,498,000. Westfield Capital Management Co. LP lifted its holdings in shares of HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after acquiring an additional 701,819 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. purchased a new position in HealthEquity in the second quarter worth $492,000. Artisan Partners Limited Partnership grew its position in HealthEquity by 44.8% in the second quarter. Artisan Partners Limited Partnership now owns 621,647 shares of the company’s stock worth $65,124,000 after acquiring an additional 192,252 shares in the last quarter. Finally, First American Bank bought a new position in HealthEquity in the third quarter valued at $1,633,000. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Stock Performance

NASDAQ:HQY opened at $85.37 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65. The firm has a market cap of $7.29 billion, a PE ratio of 39.16, a price-to-earnings-growth ratio of 1.26 and a beta of 0.20. The business has a 50 day moving average price of $96.16 and a 200-day moving average price of $94.60.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The company had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm’s revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Barrington Research reaffirmed an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a research note on Thursday, December 4th. Weiss Ratings reissued a “hold (c+)” rating on shares of HealthEquity in a report on Wednesday, October 8th. The Goldman Sachs Group lowered HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price for the company. in a research note on Friday, January 9th. Barclays initiated coverage on shares of HealthEquity in a research note on Monday, December 8th. They set an “overweight” rating and a $118.00 price target on the stock. Finally, Wall Street Zen lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Sunday, January 11th. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $119.60.

Insider Activity

In related news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the transaction, the executive vice president owned 45,742 shares in the company, valued at $4,366,073.90. The trade was a 19.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at $7,007,290.88. The trade was a 1.99% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 15,459 shares of company stock worth $1,483,062 over the last three months. 1.50% of the stock is owned by insiders.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.